14 October 2018 | News
This plant is expected to become one of the largest facilities in the next few years.
Sun Pharma is planning to invest an additional Rs 200 crore at its plant in Assam to augment operations. The company has already invested Rs 700 crore in this manufacturing facility.
Sun Pharma has invested Rs 120 crore to set up this new production line, which will boost the capacity to manufacture liquid vials, injectables, eye drops and tablets among others.
This plant is expected to become one of the largest facilities in the next few years in the company's network to manufacture sterile products.